Dr. Manfred Franz Buechele

D.M.D. | Dentist



  
  12344 Roper Blvd, Clermont
  Florida, 34711-4300

  352-242-1763    Maps & Directions
Dr. Manfred Franz Buechele is a Clermont, Florida based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 12344 Roper Blvd, Clermont. Patients can reach him at 352-242-1763.
Dr. Manfred Franz Buechele is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Manfred Franz Buechele speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Manfred Franz Buechele
Specialization: Dentist
Gender:Male
Credentials: D.M.D.
Accepts Medicare Assignment:May Accept
Practice Address:12344 Roper Blvd, Clermont,
Florida, 34711-4300
Phone:352-242-1763
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 4789982984
Enrollment ID: I20160420001658
NPI Number: 1285894956
NPI Enumeration Date: 16 Jun, 2008
NPI Last Update On: 25 Mar, 2024

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 12344 Roper Blvd,
Clermont, Florida
Zip: 34711-4300
Phone Number: 352-242-1763
Patients can reach Dr. Manfred Franz Buechele at 12344 Roper Blvd, Clermont, Florida or can call to book an appointment on 352-242-1763. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: